Ligand Pharmaceuticals
LGND
LGND
269 hedge funds and large institutions have $2.52B invested in Ligand Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 99 increasing their positions, 99 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $2.5B → $2.52B (+$19.6M)
0% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 99
34% less call options, than puts
Call options by funds: $31.8M | Put options by funds: $47.9M
Holders
269
Holding in Top 10
8
Calls
$31.8M
Puts
$47.9M
Top Buyers
| 1 | +$52.9M | |
| 2 | +$29.3M | |
| 3 | +$23.5M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$19.1M |
| 5 |
CCMLC
Cardinal Capital Management LLC (Connecticut)
Greenwich,
Connecticut
|
+$9.51M |
Top Sellers
| 1 | -$48.2M | |
| 2 | -$14.5M | |
| 3 | -$14.3M | |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$13.1M |
| 5 |
TA
Teachers Advisors
New York
|
-$11.7M |